Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
09/16/2004 | US20040180829 Compounds and methods for regulating bacterial growth and pathogenesis |
09/15/2004 | EP1456193A1 PREPARATION OF TRANS-FUSED 3,3a,8,12b-TETRAHYDRO-2 i H /i -DIBENZO 3,4:6,7]CYCLOHEPTA 1,2-b]FURAN DERIVATIVES |
09/15/2004 | EP1456192A1 Deuterated substituted dihydrofuranones and medicaments containing these compounds |
09/15/2004 | EP1456170A1 Aminoacetonitrile derivatives and their use for controlling parasites |
09/15/2004 | EP1237884B1 Process for the preparation of trans-3-alkyloxy-4-hydroxytetrahydrofuran |
09/15/2004 | EP1140887B1 Phase transfer catalyzed method for preparing oxybisphthalic compounds |
09/15/2004 | EP1024896B1 Process for regeneration of carbon-supported, rhenium-containing catalysts |
09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
09/15/2004 | EP0702517B1 Quaternary ammonium and waterproofing/preservative compositions |
09/15/2004 | CN1528756A Technical method for extracting salvianolic acid B from radix salivae miltiorrhizae |
09/15/2004 | CN1528755A Method for synthesizing conjugate vitaminc linoleate |
09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
09/15/2004 | CN1166782C Continuous process for preparing optically pure (S)-3,4-dihydroxybutyric acid derivatives |
09/15/2004 | CN1166781C Continous process for preparing optically pure (S)-3-hydroxy-gamma-butyrolactone |
09/15/2004 | CN1166660C Process for preparing N-methyl piperethanamine salt |
09/15/2004 | CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
09/15/2004 | CN1166657C Dihydrofuran heterocyclic compounds and synthesis process thereof |
09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
09/14/2004 | US6790997 Oxidation of alcohols in the presence of osmium compounds as catalysts in water or a solvent mixture |
09/14/2004 | US6790973 Reduction of ketone to alcohol using complex catalyst |
09/14/2004 | US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient |
09/14/2004 | US6790834 Cytostatic agents |
09/14/2004 | CA2280708C Cetp activity inhibitors |
09/14/2004 | CA2264549C Spirocyclic dopamine receptor subtype ligands |
09/14/2004 | CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines |
09/10/2004 | WO2004076436A1 Method for preparing oxydiphthalic anhydrides using bicarbonate as catalyst |
09/10/2004 | WO2004076433A1 Dipeptidyl peptidase inhibitors |
09/10/2004 | WO2004075853A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
09/10/2004 | WO2004050795A3 Antioxidant-functionalized polymers |
09/10/2004 | WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors |
09/10/2004 | WO2004043392B1 Mucin synthesis inhibitors |
09/10/2004 | WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
09/10/2004 | WO2003079984A3 Substituted tetracycline compounds |
09/10/2004 | CA2515842A1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
09/09/2004 | US20040176630 Methacrylate compounds with transparency patterns |
09/09/2004 | US20040176462 NPY Y5 antagonist |
09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
09/09/2004 | US20040176458 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
09/09/2004 | US20040176445 Propionic acid derivatives |
09/09/2004 | US20040176437 Novel compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
09/09/2004 | US20040176435 example compound: (3S)-3-(1-Benzothien-7-yloxy)-N-methyl-3-phenyl-1-propanamine oxalate; depression, OCD, anxiety, memory loss, urinary incontinence, conduct disorders, ADHD, obesity, alcoholism, smoking cessation and pain |
09/09/2004 | US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
09/08/2004 | EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
09/08/2004 | EP0927188B1 Novel nucleoside analogs with polycyclic aromatic groups attached, methods of synthesis and uses therefor |
09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
09/08/2004 | CN1527826A Method for the production of phthalic anhydride to a specification |
09/08/2004 | CN1527825A Method for the preparation of escitalopram |
09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
09/08/2004 | CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
09/08/2004 | CN1527809A Process for the preparation of 7-substituted 3-alkyl-3H-isobenzofuran-1-one derivatives |
09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
09/08/2004 | CN1526710A Prepn of 4-chlorophthalic anhydride |
09/08/2004 | CN1526709A 3,4,5-trisubstituted-5-hydroxy-2(5hydro)-furaldone compound and its synthesis and use |
09/08/2004 | CN1165531C Alpha-methylbenzyl-containing thioure a inhibitors of herpes viruses containing phenylenedimine group |
09/08/2004 | CN1165508C Methyl oxirane dibenzoylressorinol UV absorbers |
09/08/2004 | CN1165505C Method for selective hydrolysis of acetals or ketals compound in presence of 2-benzo [c] furanone |
09/08/2004 | CN1165337C Synthetic cryptophycins |
09/07/2004 | US6787671 Catalytic osmium-assisted oxidative cleavage of olefins |
09/07/2004 | US6787570 Administering an aromatic or heteroaromatic substituted tertiaryamine compound to treat atherosclerosis, dyslipidemia, and other coronary artery diseases |
09/07/2004 | US6787536 Hydroxamic acid derivatives |
09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
09/02/2004 | WO2004074242A2 Halogenated oxime derivatives and the use thereof as latent acids |
09/02/2004 | WO2004074236A1 Novel transcriptional factor, process for producing the same and use thereof |
09/02/2004 | WO2004073709A1 Antimicrobial agents |
09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
09/02/2004 | WO2004041256A3 Safe chemical uncouplers for the treatment of obesity |
09/02/2004 | WO2003049698A8 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
09/02/2004 | US20040171894 Process for the catalytic oxidation of hydrocarbons |
09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/02/2004 | US20040171866 Transistros; liquid crystals display; electrooptics |
09/02/2004 | US20040171851 Process for the preparation of 5-carboxyphthalide |
09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
09/02/2004 | US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon |
09/02/2004 | US20040171677 for combatting neuropathic pain.for the treatment of neurodegenerative diseases, preferably of Alzheimer's disease, Parkinson's disease or Huntington's chorea, migraine, stroke, cerebral ischaemia, cerebral infarct, cerebral edema, schizophrenia |
09/02/2004 | US20040171662 Biaryl-type compounds, CD color fixing agent and method for determination of absolute configuration |
09/02/2004 | US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide |
09/02/2004 | US20040171612 Novel compounds with analgesic effect |
09/02/2004 | US20040171491 Substituted benzoylcyclohexenones and their use as herbicidal agents |
09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
09/02/2004 | CA2512883A1 Sulfonamide derivatives as ppar modulators |
09/02/2004 | CA2511979A1 Halogenated oxime derivatives and the use thereof as latent acids |
09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
09/01/2004 | EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
09/01/2004 | EP1451169A1 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use |
09/01/2004 | EP1451148A2 2,w-diaminocarboxylic acid compounds |
09/01/2004 | EP1451133A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
09/01/2004 | EP1383755B1 Separation of 2,5-dihydrofuran and water from mixtures thereof by extractive distillation |
09/01/2004 | EP1242410B1 Novel compounds |
09/01/2004 | EP1183261B1 Method for separating analogous organic compounds |
09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
09/01/2004 | CN1525959A Muller Klaus-helmut |